Press releases
Press releases
Here we list English translations of the Swedish press releases published by Neola Medical AB (publ). For official press releases, please visit our Swedish website.
Neola Medical carries out a directed share issue of SEK 20 million and thereby secures financing for 2024
NOT FOR PUBLICATION, DISTRIBUTION, OR DISCLOSURE, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN AUSTRALIA, BELARUS, HONG KONG, JAPAN, CANADA, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH AFRICA, THE UNITED STATES OR ANY OTHER JURISDICTION WHERE SUCH ACTION...
Neola Medical has been granted a patent in Europe for the company’s disposables
Press communication Lund, Sweden, December 12 2023 This is a translation of the Swedish press release published 2023-12-12 Neola Medical AB (publ) announced today that the company has been granted a new patent in Europe for a strategically important invention in...
Neola Medical AB starts a subsidiary in the USA
Press communication Lund, Sweden, December 4 2023 This is a translation of the Swedish press release published 2023-12-04 Neola Medical AB (publ) has started a subsidiary in the USA as part of the upcoming launch of Neola® on the American market. The company's...
Neola Medical’s CEO tells more about the latest news in the investor letter for autumn 2023
Press communication Lund, Sweden, November 15 2023 This is a translation of the Swedish press release published 2023-11-15 Market preparations for launch in the U.S. continue with a new exclusive collaboration with Stanford, enhanced protection for Neola® through...
Neola Medical Q3 report 2023 – Doors open in the U.S. with Stanford support and new strong final results from independent clinical trial in newborns
This is a translation of the Swedish press release published 2023-11-09, 07:55 CET New successful results from the completed independent clinical trial in Ireland show that Neola® measures oxygen in the lungs of 100% of the participating 100 newborn babies....
Neola Medical invites to presentation of the Q3-report 2023
Press communication Lund, Sweden, November 2nd, 2023 This is a translation of the Swedish press release published 2023-11-02 Neola Medical AB (publ) invites to presentation of the Q3-report of 2023, Thursday the 9th of November 2023 at 9am CET (09.00). The...
Stanford selects Neola Medical’s medical technology product as an important innovation for neonatal care and gives the company support to market launch through the exclusive program Impact1
Press communication Lund, Sweden, October 12, 2023 This is a translation of the Swedish press release published 2023-10-12 Neola Medical is one of the few companies that have been selected to receive support from the Stanford University (Stanford) Impact1 program....
New successful results from clinical study on 100 newborn babies with Neola Medical’s medical device
Press communication Lund, Sweden, October 10, 2023 This is a translation of the Swedish press release published 2023-10-09 At the jENS conference in Italy on September 23, 2023, the clinical researcher and neonatologist Jurate Panaviene presented new results and...
Neola Medical AB appoints ABG Sundal Collier as liquidity provider
Press communication Lund, Sweden, August 17, 2023 This is a translation of the Swedish press release published 2023-08-17 Neola Medical AB (the “Company”) has appointed ABG Sundal Collier (“ABGSC”) as liquidity provider for the Company’s shares listed on Nasdaq...
Neola Medical Q2 report 2023 – Intensified work in the market preparations before launch in the U.S.
This is a translation of the Swedish press release published 2023-08-15, 08.00 CEST Neola Medical AB (publ) today publishes the Q2 report of 2023 (in Swedish). The report is available at the company's website and is attached to the press release. During the...
